XM does not provide services to residents of the United States of America.

TSX loses monthly winning streak as US rate cut prospects ebb



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>CANADA STOCKS-TSX loses monthly winning streak as US rate cut prospects ebb</title></head><body>

TSX ends down 1.35% at 21,714.54

For the month, the index loses 2%

Resource shares lead declines

Tilray Brands surges as DOJ reclassifies pot

Updates at market close

By Fergal Smith

April 30 (Reuters) -Canada's main stock index fell on Tuesday, extending its monthly decline, as commodity prices dropped and U.S. labor cost data added to investor concerns that the Federal Reserve would be unlikely to begin cutting interest rates in the coming months.

The Toronto Stock Exchange's S&P/TSX composite index .GSPTSE ended down 297.08 points, or 1.35%, at 21,714.54, For the month, the index was down 2%, its first monthly decline since October.

"The numbers out of the U.S. this morning showed wage inflation remaining sticky," said Allan Small, senior investment advisor of the Allan Small Financial Group with iA Private Wealth. "The Fed doesn't look to be cutting rates anytime soon."

U.S. stocks also traded lower as markets weighed economic data showing labor costs rose more than expected last quarter on the eve of a key Fed policy meeting.

The energy sector .SPTTEN tumbled 3.1% as the price of oil settled 0.9% lower at $81.93 a barrel on the back of rising U.S. crude production as well as hopes of an Israel-Hamas ceasefire.

The materials group .GSPTTMT, which includes metal miners and fertilizer companies, was also down 3.1% as gold and copper prices fell, with Ivanhoe Mines Ltd IVN.TO tumbling 9.5% after the company reported quarterly results.

Domestic data showed that gross domestic product increased 0.2% in February, which was less than economists had expected.

Restaurant Brands QSR.TO was a bright spot. Its shares gained 3.5% after the company's quarterly results beat analysts' estimates, while the shares of Tilray Brands Inc TLRY.TO jumped 41.9% as the U.S. Department of Justice moved to reclassify marijuana as a less dangerous drug.



Reporting by Fergal Smith in Toronto and Purvi Agarwal in Bengaluru; Editing by Vijay Kishore and Jonathan Oatis

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.